Robert Mayer & Peter Weisz 
Without Risk There’s No Reward: Tales, Trials and Truisms from the Amazing Life of a Pioneering Southern California Developer [EPUB ebook] 

Cost models underlie all the techniques used in construction cost and price forecasting, yet until relatively recently industry has been unfamiliar with their characteristics and properties. An under …

You likely don’t need any more tools, programs, or workshops to improve your hospital. What you need is a simple and consistent approach to manage problem-solving. Filling this need, this book presen …

There is no simple strategic method for dealing with the multidimensional nature of digital change. Even the sharpest leaders can become disoriented as change builds on change, leaving almost nothing …

This book examines the dynamic relationship and volatility spillovers between crude oil prices, exchange rates and stock markets of emerging economies. Although considerable literature on relationshi …

Case Study Research: Core Skills in Using 15 Genres examines the processes involved in conducting case research in a number of genres including participant observation, fuzzy set social science, syst …

The future of work in advanced industrial democracies is the subject of intense debate and public concern. Despite predictions that working hours would fall and leisure time would rise as society pro …

This original, quantitatively oriented analysis applies the theory of the core to define competition in order to describe and deduce the consequences of competitive and non-competitive behavior. Writ …

A good business case is so much more than simply the means to justify a decision. A well-written and well-researched business case will secure funding; make sure any project stays on the right side o …

This book presents an in-depth analysis of the functional dynamics of Indian industrial clusters which have grown and stayed as hubs of business activity in India, thanks to a large calibrated domest …

Appraising cancer as a major medical market in the 2010s, Wall Street investors placed their bets on single-technology treatment facilities costing $100-$300 million each. Critics inside medicine cal …